Latest in Novo Nordisk's Glp
Sort by
3 items
-
FDA approves GLP-1 generic for Type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...The Hill - 8h -
European markets open higher in shortened session ahead of Christmas; Novo Nordisk resumes recovery
European stocks edged higher at the open on Tuesday.CNBC - 20h -
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza
The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.NBC News - 1d